AUS
NZ
UK
CA
USA
IND
Healthcare
Is Mesoblast Revolutionizing Stem-Cell Therapy for Inflammatory Diseases?
January 29, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Mesoblast's Ryoncil therapy gains FDA approval for treating children with steroid-resistant Graft-versus-Host Disease (GvHD).,The company secured significant funding to expand its therapies for chronic heart disease and back pain.,Mesobla...
When Might Cyclopharm Limited (ASX:CYC) Become Profitable?
January 28, 2025 07:30 PM AEDT| By Team Kalkine MediaHighlights,Cyclopharm Limited is nearing breakeven,Average annual growth rate of 105% expected,No debt on balance sheet,Cyclopharm Limited (,ASX: CYC,), a prominent player in the medical equipment and radiopharmaceutical market across the Asia Pacifi...
Sigma Healthcare Shares Surge 10% Amid Strong Merger Partner Performance
January 28, 2025 02:16 PM AEDT| By Team Kalkine MediaHighlights,Sigma Healthcare shares rise 10.2% to AU$2.975, marking their highest level since January 14, as merger news boosts investor confidence.,Chemist Warehouse, SIG's merger partner, reports 13% growth in retail sales, with record 10.3% like-fo...
Arovella Therapeutics (ASX:ALA) Surges with 71% CAGR in Three Years, Rising 11% This Week
January 28, 2025 01:31 PM AEDT| By Team Kalkine MediaArovella Therapeutics (ASX:ALA) has provided its shareholders with an impressive compound annual growth rate (CAGR) of 71% over the past three years, with an 11% increase in the last week alone.
Radiopharmaceutical Expansion Sparks Telix Pharmaceuticals (ASX:TLX) Momentum
January 28, 2025 12:52 PM AEDT| By Team Kalkine MediaHighlights:,Acquisition of RLS,Radiopharmacies,bolsters commercial infrastructure and distribution in the US,Telix,Pharmaceuticals (,ASX:TLX,) records over +150% year-on-year returns amid broader biotech rally,Radiopharmaceutical advancements support...
Health Check: Alterity Seeks Accelerated FDA Approval Following Positive Trial Outcomes for Parkinson's-like Disorder
January 28, 2025 11:00 AM AEDT| By Team Kalkine MediaBreakthroughs and Market Movements in Medical Innovations
Imricor Secures CE Mark Certification for Vision-MR Ablation Catheter under New MDR Standards
January 28, 2025 11:00 AM AEDT| By Team Kalkine MediaImricor Secures CE Mark Certification for Vision-MR Ablation Catheter under New MDR Standards
What Makes This Hidden Stock the Center of Attention Right Now?
January 27, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Bio-Gene Technology secures US military grants for natural insecticide development.,ASX biotech companies show impressive revenue growth.,"Made in America" policies encourage US-based manufacturing expansions in the life sciences sector.,...
Could Wellnex's Global Expansion Transform Healthcare Branding?
January 26, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Wellnex (ASX:WNX) secures funds for a secondary listing in London.,Transition from a brand broker to an owner of consumer healthcare brands is underway.,Strategic partnerships and international expansion are driving operational changes,The...
Is Cochlear Limited's (ASX:COH) Recent Stock Performance Driven by Its Appealing Financial Outlook?
January 25, 2025 11:31 AM AEDT| By Team Kalkine MediaHeadlines,Significant stock increase observed for Cochlear Limited (,ASX:COH,).,The company showcases impressive Return on Equity (ROE).,Maintains steady dividend distribution alongside earnings growth.,Cochlear Limited's (ASX:COH) Recent Surge and R...
Can EBR Systems Revolutionize Cardiac Care?
January 25, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,EBR Systems (ASX:EBR) awaits regulatory authorization for an innovative leadless pacemaker.,The device transforms ultrasound energy into targeted stimulation of the heart's left ventricle.,A selective market introduction and Silicon Valley...
Is BlinkLab's Dx 1 Platform Set to Redefine Autism Diagnostics?
January 25, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,BlinkLab (ASX:BB1) embarks on a US autism diagnostic trial in collaboration with two respected clinical centers.,The trial evaluates the Dx 1 platform, which employs advanced smartphone sensor technology to capture subtle auditory response...
AI-Powered Lung Disease Diagnosis Achieves 96.57% Accuracy
January 24, 2025 03:26 PM AEDT| By Team Kalkine MediaHighlights:,AI model achieves 96.57% accuracy in diagnosing respiratory diseases through lung ultrasound analysis.,The model provides visual explanations to enhance radiologists' trust and decision-making.,Potential applications include detecting con...
Clarity Pharmaceuticals (ASX:CU6) Gains FDA Fast Track Status for PET Scan Imaging Agent
January 24, 2025 03:00 PM AEDT| By Team Kalkine MediaHighlights,Clarity Pharmaceuticals (ASX:CU6) secures FDA fast-track designation for its Cu-64 SAR-,bisPSMA,imaging agent targeting recurrent prostate cancer.,The company's market capitalization surpasses $1 billion, reflecting investor confidence ami...
4DMedical (ASX:4DX) Expands Commercial Presence with Qscan Radiology Clinics Agreement
January 24, 2025 02:02 PM AEDT| By Team Kalkine MediaHighlight:,4DMedical Ltd (ASX:4DX) secures a commercial agreement with,Qscan,Radiology Clinics for lung health assessment products.,The agreement marks the first commercial contract in Australia to feature the Pulmonary Function and Pulmonary Structu...
Clarity Pharmaceuticals (ASX: CU6) Rises 3.5% on FDA Fast Track Designation for 64Cu-SAR-bisPSMA
January 24, 2025 01:52 PM AEDT| By Team Kalkine MediaHighlights,Clarity Pharmaceuticals (ASX:CU6) share price up 3.5%, reaching AUD 4.20.,FDA grants Fast Track Designation for 64Cu-SAR-bisPSMA in prostate cancer imaging.,This milestone marks a significant step forward in Clarity's bisPSMA program.,In t...
Are ASX Healthcare Stocks Showing a New Trend?
January 24, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,ASX health sector has recorded a modest upward trend with diverse share price fluctuations across various companies.,EBR Systems achieves a regulatory milestone through an FDA manufacturing pre-approval inspection and entry into the TCET r...
We believe that Clarity Pharmaceuticals (ASX:CU6) is well-positioned financially to support its business growth.
January 24, 2025 09:30 AM AEDT| By Team Kalkine MediaExploring Clarity Pharmaceuticals' Cash Position
Dusk Group Tops the List of 3 ASX Penny Stocks
January 23, 2025 05:26 PM AEDT| By Team Kalkine MediaBoosted Optimism as ASX200 Reaches New Highs
ASX Stocks Potentially Undervalued in January 2025
January 23, 2025 05:26 PM AEDT| By Team Kalkine MediaAustralian Stock Market's Positive Swing and Undervalued Opportunities
Advertise your brand on Kalkine Media